Word

MYQUISTA

Status

Pending

Status Code

653

Status Date

Thursday, October 26, 2023

Serial Number

97703857

Mark Type

4

Filing Date

Monday, December 5, 2022

Trademark Owner History

TEVA PHARMACEUTICALS USA, Inc.

Classifications

5 Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Trademark Events

Dec 8, 2022

New Application Entered

Dec 8, 2022

New Application Office Supplied Data Entered

Sep 12, 2023

Assigned To Examiner

Sep 13, 2023

Non-Final Action Written

Sep 13, 2023

Non-Final Action E-Mailed

Sep 13, 2023

Notification Of Non-Final Action E-Mailed

Oct 24, 2023

Teas Response To Office Action Received

Oct 24, 2023

Correspondence Received In Law Office

Oct 25, 2023

Teas/Email Correspondence Entered

Oct 26, 2023

Letter Of Suspension E-Mailed

Oct 26, 2023

Suspension Letter Written

Oct 26, 2023

Notification Of Letter Of Suspension E-Mailed

Apr 26, 2024

Suspension Checked - To Attorney For Action